CIK 0001048477 · Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680397820
- Phone
- 4155066700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-25 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +6,675 | 94,068 | ||
| 2026-02-25 | Guyer Charles Greg EVP, Chief Technical Officer | Grant or award | +2,371 | 96,439 | ||
| 2026-02-25 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +6,177 | 89,467 | ||
| 2026-02-25 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +6,675 | 96,142 | ||
| 2026-02-25 | Davis George Eric EVP, Chief Legal Officer | Grant or award | +2,372 | 98,514 | ||
| 2026-02-25 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +6,683 | 106,839 | ||
| 2026-02-25 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +7,230 | 114,069 | ||
| 2026-02-25 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +2,569 | 116,638 | ||
| 2026-01-20 | Ramchandani Rashmi Virendra VP, Chief Accounting Officer | Grant or award | +18,540 | 18,540 | ||
| 2026-01-20 | Ramchandani Rashmi Virendra VP, Chief Accounting Officer | Grant or award | +7,070 | 25,610 | ||
| 2026-01-20 | Ramchandani Rashmi Virendra VP, Chief Accounting Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +18,220 | 18,220 | ||
| 2025-12-01 | Hardy Alexander Chief Executive Officer | Shares withheld for taxes | −16,570 | $55.03 | $912K | 159,388 |
| 2025-09-30 | Friberg Gregory R EVP, Chief R&D Officer | Shares withheld for taxes | −3,304 | $54.16 | $179K | 43,506 |
| 2025-08-01 | CLARK IAN T Director | Grant or award | +7,000 | 7,000 | ||
| 2025-05-20 | Hubbard Cristin EVP, Chief Commercial Officer | Shares withheld for taxes | −2,155 | $59.93 | $129K | 30,545 |
| 2025-05-20 | Walbert Timothy P Director | Grant or award | +6,650 | 9,780 | ||
| 2025-05-20 | MEIER RICHARD A Director | Grant or award | +6,650 | 127,426 | ||
| 2025-05-20 | HOMBACH ROBERT J. Director | Grant or award | +6,650 | 41,870 | ||
| 2025-05-20 | Ho Maykin Director | Grant or award | +6,650 | 28,010 | ||
| 2025-05-20 | Enyedy Mark J Director | Grant or award | +6,650 | 13,550 |
Page 3 of 10 · 187 trades